A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial

Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori

(2018) Min Li et al.   HELICOBACTER

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication

(2016) Seng-Kee Chuah et al.   MEDICINE

High Dose Ilaprazole/Amoxicillin as First-Line Regimen forHelicobacter pyloriInfection in Korea

(2016) WonGun Kwack et al.   Gastroenterology Research and Practice

High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection

(2015) Jyh-Chin Yang et al.   Clinical Gastroenterology and Hepatology

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication ofHelicobacter pyloriin the community and hospital populations: a randomised trial

(2015) Jyh-Ming Liou et al.   GUT

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-LineHelicobacter pyloriEradication

(2015) Wei-Chen Tai et al.   Biomed Research International

High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy forHelicobacter pyloriInfections

(2014) Taraq A. Attumi et al.   HELICOBACTER

New dual therapy for primary treatment ofHelicobacter pyloriinfection: A prospective randomized study in Shanghai, China

(2014) Ling Ren et al.   Journal of Digestive Diseases

The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication

(2014) Wei-Chen Tai et al.   PLoS One

Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice

(2014) Wei-Chen Tai et al.   Biomedical Journal

The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study

(2012) Seng-Kee Chuah et al.   HELICOBACTER

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2012) Jyh-Ming Liou et al.   LANCET

Optimal therapy for Helicobacter pylori infections

(2011) Emiko Rimbara et al.   Nature Reviews Gastroenterology & Hepatology

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States

(2010) David Y. Graham et al.   JOURNAL OF GASTROENTEROLOGY

Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection

(2009) Deng–Chyang Wu et al.   Clinical Gastroenterology and Hepatology

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Therapy for Helicobacter pylori Infection Can be Improved

(2008) David Y Graham et al.   DRUGS

Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures

(2008) P. I. Hsu et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION